DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

download DSM V C 1 -  Overview of Substance Use Disorders - Kanehl.pdf

of 118

Transcript of DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    1/118

    Sandy Kanehl, M.Ed., CSAC, Mid-Atlantic ATTC

    April 26, 2012, Charleston, WV

    Overview of Substance Use Disorders

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    2/118

    Your Mid-Atlantic Addiction Technology Transfer Center

    serves West Virginia, KY, TN, and VA

    VCU

    We are located at

    Virginia Commonwealth

    University

    http://www.attcnetwork.org/regcenters/indexmidatlantic.asp

    [email protected]

    http://www.attcnetwork.org/regcenters/indexmidatlantic.aspmailto:[email protected]:[email protected]://www.attcnetwork.org/regcenters/indexmidatlantic.asp
  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    3/118

    Our objectives today: Learn current info on drugs of abuse,

    trends, prevalence, basic addiction science Understand proposed changes for SUD Dx

    in DSM-V

    Identify new trends in the fieldRM, ROS,

    impact of HCR

    Discuss implications of theabove for clinical practice

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    4/118

    Whos here?

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    5/118

    Context

    What are the most stigmatized

    illnesses in our culture? How does the public view

    substance misuse/people

    with SUDs? How do professionals view

    people with SUDs?

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    6/118

    One more context slide How many of us personally know someone who

    has struggled with SUD?

    know someone who has tried but could not access

    services? Why?

    know someone whos been administratively

    discharged from Tx for exhibiting the Sx of the illness

    for which they are being treated?

    What is the general publics view of

    addiction treatment?

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    7/118

    Drugs of abuse, trends, prevalence, basic addictionscience

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    8/118

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    9/118

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    10/118

    Emerging Drugs K2/Spice

    diverse family of herbal mixtures marketed under many names, including fakemarijuana, Yucatan Fire, Skunk, Moon Rocks, and others. Products contain dried,

    shredded plant material and presumably, chemical additives that are responsible fortheir psychoactive effects. Sold in head shops, gas stations, and via the Internet

    Salvia herb with main active ingredient salvinorin A, a potent activator of kappa opioid

    receptors in the brain; different receptors from the commonly known opioids, such asheroin and morphine. Ingested by chewing fresh leaves or by drinking their juices. Driedleaves can also be smoked as a joint, consumed in water pipes, or vaporized and

    inhaled. Not regulated yet but DEA has listed Salvia as a drug of concern and isconsidering classifying it as a Schedule I drug, like LSD or marijuana.

    Bath Salts newer fad, synthetic powders sold under names like Ivory Wave, Red Dove, Blue Silk,

    Zoom often amphetamine-like chemicals, used orally, by inhalation, or injection, notyet well understood but linked to alarming number of ER visits across the country

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    11/118

    Trends NSDUH April 2011 Report Overall underage (12-20) alcoholuse incl. binge drinking

    showed gradual decline

    12% of pop 12 & older (30.2 million) drove under the influenceof ETOH past yr. (down from 14.2 % in 2002)

    Tobaccouse has declined; from 2002 to 2009, rate of past-month cigarette use fell from 13.0 percent to 8.9 percentamong 12- to 17-year-olds. Among young adults aged 18 to

    25 years; rates of use fell from 40.8 percent in 2002 to 35.8percent in 2009

    In 2010, 12th graders reported an annual prevalence rate of17% for hookahsmoking and 23% for the use of small cigars.

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    12/118

    Trends NSDUH April 2011 Report Dailymarijuanause increased among 8th, 10th, and 12th graders

    from 2009 to 2010. Among 12th graders, use was at its highest

    point since the early 1980s, at 6.1 percent. Perceived risk ofregular marijuana use also declined among 10th and 12th graders,suggesting future trends in use may continue upward.

    Trends in lifetime use of amphetamineand methamphetamineindicate statistically significant declines from peak-year (1996) use

    among high schoolers. Cocaineuse gradually declined between 2003 and 2009 among

    people aged 12 or older (from 2.3 million to 1.6 million).

    From 2009 to 2010, lifetime use of ecstasyamong 8-10th gradersincreased from 2.2 percent to 3.3 percent

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    13/118

    Trends NSDUH April 2011 Report Rates of hallucinogenuse remained unchanged from 2009 to

    2010, although significant increases were reported by 12th

    graders for annual and past-month use of LSD. Past-year use of inhalantsalso remained steady from 2009 to

    2010 with 8% of 8th graders reporting past-year use.

    Prescriptionand OTC medications accounted for most of thetop drugs abused by 12th graders in the past year.

    Nonmedical use of Vicodin decreased from 9.7% to 8.0%however, nonmedical use of Oxycontin remained unchanged,& has increased among 10th graders over the past 5 years.Nonmedical use of Adderall and OTC cough and cold medsremained high at 6.5 percent and 6.6 percent, respectively.

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    14/118

    National Data The annual total estimated societal cost of substance abuse in

    the United States is $510.8 billion

    In 2009, an estimated 23.5 million Americans aged 12 and olderneeded treatment for substance use

    Half of all lifetime cases of mental and substance use disordersbegin by age 14 and three-fourths by age 24

    Source: Substance Abuse and Mental Health Services Administration,Leading Change: A Plan for SAMHSAs Roles and Actions 2011-2014

    Executive Summary and Introduction. HHS Publication No. (SMA) 11-

    4629 Summary. Rockville, MD: Substance Abuse and Mental Health

    Services Administration, 2011.

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    15/118

    Trends in West Virginia Spice Not the community, (synth et ic cannabinoids), & regular marijuana

    Bath Salts DOPE not SOAP (Synthet ic cath inones)West Virginiais hoping to curb synthetic drug use with a ban. The legislature has approved a bill thatwould make buying, selling or possessing synthetic drugs illegal. The move came afterthe state's poison control center reported 80 cases of people using bath salts to get highsince the start of 2011. That's compared to three in all of 2010. (WTAP News, 3/19/2011)

    Public confusion As evidenced by public comments on above article

    Pain meds/pill mills Growing problem of illegal sales of Rx drugs-Significantopioid research at WVU

    Methamphetamine pockets of abuse (DEA data)

    Gambling

    Health disparities plus access & capacity issues,stigma, poverty

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    16/118

    Meth Notes rebounding after decline rural areas experiencing greater

    increases in use availability on the rise smurfing and shake & bakecontribute to this 19.3 = average age of initiation, need prevention & treatment

    resources!

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    17/118

    From the Governors desk in Coal Valley News, April 3, 2012

    Drug overdoses now kill more West Virginians thancar accidents

    Drugs are the leading cause of accidental deaths inour state

    We have the nations highest rate of drug deaths

    9 out of 10 of our overdose deaths involve at leastone prescription drug http://www.coalvalleynews.com/view/full_story/18083312/articl

    e-FIGHTING-DRUG-ABUSE-IN-WEST-VIRGINIA

    http://en.wikipedia.org/wiki/File:Seal_of_West_Virginia.svghttp://en.wikipedia.org/wiki/File:Seal_of_West_Virginia.svg
  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    18/118

    Illicit Drug Dependence Past Year Persons Aged 12 & Older in WV

    Source: SAMHSA, Office of Applied Studies, NationalSurvey on Drug Use and Health, 2006, 2007, and 2008.

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    19/118

    Nonmedical Use of Pain Relievers Persons Aged 12 or Older in WV

    Source: SAMHSA, Office of Applied Studies, National Surveyon Drug Use and Health, 2006, 2007, and 2008.

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    20/118

    Alcohol Use Past Month among Persons Aged 12 -20 in WV

    Source: SAMHSA, Office of Applied Studies, National Survey onDrug Use and Health, 2006, 2007, and 2008.

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    21/118

    Needing but Not Receiving Treatment for Drug Use Past

    Year Persons 12 & Older in West Virginia

    Source: SAMHSA, Office of Applied Studies, National Surveyon Drug Use and Health, 2006, 2007, and 2008.

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    22/118

    DSM-V Revisions reflect

    major change!

    Here is your resource to

    follow the progress:http://www.dsm5.org/Pages/D

    efault.aspx

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    23/118

    DSM-Vhttp://www.dsm5.org/Pages/Default.aspx

    Proposed changes affecting former

    Dx of substance abuseand dependence Coming out May 2013

    Field trials underway in large academic-medical settings and small solo/grouppractices

    Two previous comment periods; third andfinal planned for spring 2012

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    24/118

    Substance Use & Addictive Disorders

    (formerly Substance-Related Disorders)

    Substance Use Disorders

    Substance Intoxication Substance Withdrawal

    Gambling Disorder

    Non-substance addictions recommended for inclusionthis moved from Impulse Control Disorders, NOS

    Substance Induced Disorders

    Also to be listed in chapter with disorder

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    25/118

    R 00-10 Substance Use Disorders

    R Substance Use DisorderR 00 Alcohol Use DisorderR 01 Amphetamine UseDisorderR 02 Cannabis Use DisorderR 03 Cocaine Use DisorderR 04 Hallucinogen Use Disorder

    R 05 Inhalant Use Disorder

    R 06 Opioid Use Disorder

    R 07 Phencyclidine Use

    DisorderR 08 Sedative, Hypnotic, or

    Anxiolytic Use Disorder

    R 09 Tobacco Use Disorder

    R 10 Other (or Unknown)Substance Use Disorder

    http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=431http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=452http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=453http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=453http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=454http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=455http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=456http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=460http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=462http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=462http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=464http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=464http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=459http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=461http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=461http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=461http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=461http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=459http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=464http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=464http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=464http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=464http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=462http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=462http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=462http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=462http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=460http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=460http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=460http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=460http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=456http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=455http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=454http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=453http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=453http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=452http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=431
  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    26/118

    SUD Definition A maladaptive pattern of substance use leading to clinically

    significant impairment or distress, as manifested by 2 (or

    more) of the following, occurring within a 12-month period: recurrent substance use resulting in a failure to fulfill major role

    obligations

    recurrent substance use in situations in which it is physicallyhazardous

    continued substance use despite having persistentor recurrent social or interpersonal problems

    Tolerance

    Withdrawal

    to # 11

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    27/118

    Specifiers

    Severitymoderate to severe

    With/without physiological dependence

    Courseearly full remission, earlypartial, sustained full, sustained partial,on agonist therapy, in controlledenvironment

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    28/118

    Why they got rid of abuseProblems identified with the DSM-IV division between

    abuse and dependence led to many studies of the

    structure of the abuse and dependence in a varietyof general population and clinical settings. Giventhe empirical evidence, the DSM-5 Substance UseDisorders Workgroup recommends combining

    abuse and dependence into a single disorder ofgraded clinical severity, with two criteria required tomake a diagnosis.

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    29/118

    Substance IntoxicationR 11-21 Substance

    Intoxication

    R 11 Alcohol IntoxicationR 12 Amphetamine

    Intoxication

    R 13 Caffeine Intoxication

    R 14 Cannabis Intoxication

    R 15 Cocaine Intoxication

    R 16 Hallucinogen Intoxication

    R 17 Inhalant Intoxication

    R 18 Opioid IntoxicationR 19 Phencyclidine Intoxication

    R 20 Sedative, Hypnotic, orAnxiolytic IntoxicationR

    21 Other (or Unknown) SubstanceIntoxication

    http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=248http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=265http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=265http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=37http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=276http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=283http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=294http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=304http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=317http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=328http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=338http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=338http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=353http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=353http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=353http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=353http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=353http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=353http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=353http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=353http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=338http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=338http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=338http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=338http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=328http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=317http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=317http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=317http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=317http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=304http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=294http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=283http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=276http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=37http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=265http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=265http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=248
  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    30/118

    Substance Withdrawal

    R 22-30 SubstanceWithdrawal

    R 22 Alcohol Withdrawal

    R 23 AmphetamineWithdrawal

    R 24 Caffeine Withdrawal

    R 25 Cannabis Withdrawal

    R 26 Cocaine Withdrawal

    R 27 Opioid Withdrawal

    R 28 Sedative, Hypnotic, orAnxiolytic Withdrawal

    R 29 Tobacco Withdrawal

    R 30 Other (or Unknown)Substance Withdrawal

    http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=249http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=266http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=266http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=553http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=430http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=284http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=318http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=339http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=339http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=313http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=354http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=354http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=354http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=354http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=313http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=339http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=339http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=339http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=339http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=318http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=318http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=318http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=318http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=284http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=430http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=553http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=266http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=266http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=249
  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    31/118

    Substance-Induced Disorders Substance-Induced Psychotic

    Disorder

    Substance-Induced BipolarDisorder

    Substance-Induced DepressiveDisorder

    Substance-Induced AnxietyDisorder

    Substance-Induced Obsessive-Compulsive or RelatedDisorders

    Substance-Induced Dissociative

    Disorder

    Substance-Induced Sleep-Wake Disorder

    Substance-Induced SexualDysfunction

    Substance-Induced Delirium

    Mild Neurocognitive DisorderAssociated with Substance

    Use Major Neurocognitive

    Disorder Associated withSubstance Use

    http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=268http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=268http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=537http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=537http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=495http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=495http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=410http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=410http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=528http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=528http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=528http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=533http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=533http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=324http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=324http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=323http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=323http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=250http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=551http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=551http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=551http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=552http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=552http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=552http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=552http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=552http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=552http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=552http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=552http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=551http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=551http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=551http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=551http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=551http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=551http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=250http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=250http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=250http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=323http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=323http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=323http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=323http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=324http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=324http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=324http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=324http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=324http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=533http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=533http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=533http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=533http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=528http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=528http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=528http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=528http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=528http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=528http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=410http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=410http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=410http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=410http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=495http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=495http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=495http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=495http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=537http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=537http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=537http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=537http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=268http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=268http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=268http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=268
  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    32/118

    Whats new? Changes in the addictions field

    Definitions

    Research

    Laws

    Services

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    33/118

    What is addiction?

    -ASAM August 2011:

    Addiction is a primary, chronic disease

    of brain reward, motivation, memoryand related circuitry- characterized by inability to consistently abstain,

    impairment in behavioral control, craving, diminished

    recognition of significant problems with ones behaviors

    and interpersonal relationships, and a dysfunctionalemotional response

    ASAMs full public policy statement may be found here:

    http://www.asam.org/research-treatment/definition-of-addiction

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    34/118

    Bringing the

    Full Power of Scienceto Bear on

    Drug Abuse& Addiction

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    35/118

    Your Brain on Drugs in the 1980s

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    36/118

    Your Brain on Drugs Today

    YELLOW

    shows places inbrain where

    cocaine binds

    (e.g., striatum)

    Fowler et al., Synapse, 1989.

    Addiction I s A Developmental Disease

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    37/118

    National Epidemiologic Survey on Alcohol and Related Condi tions, 2003.

    Age

    0.0%0.0%

    0.2%0.2%

    0.4%0.4%

    0.6%0.6%

    0.8%0.8%

    1.0%1.0%

    1.2%1.2%

    1.4%1.4%

    1.6%1.6%

    1.8%1.8%

    55 1010 1515 2121 2525 3030 3535 4040 4545 5050 5555 6060 6565

    %ineachagegroupwho

    developfirst-time

    dependence

    CANNABISALCOHOL

    TOBACCO

    Addiction I s A Developmental Disease

    that star ts in adolescence and childhood

    Age at tobacco, alcohol, and cannabisdependence per DSM IV

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    38/118

    Addiction is L ike Other Diseases

    it is preventable, it is treatable, it changes biology,if untreated, it can last a lifetime

    Healthy Brain Diseased Heart

    Decreased Heart Metabolismin Heart Disease Patient

    Decreased Brain MetabolisminDrug Addicted Patient

    Diseased Brain/

    Cocaine Addicted

    Healthy

    Heart

    High

    Low

    Research supported by NIDA addresses all of thesecomponents of addiction.

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    39/118

    Addiction is a Chronicillness & public health issue

    With similar characteristics,

    including relapse rates, to

    other chronic illnesses

    Substance use disorders

    should be insured,

    monitored, treated and

    evaluated like other chronicdiseases

    McLellan AT, Lewis DC, et al.JAMA 2000; 284:1689-1695.

    Hypertension

    Diabetes

    Asthma

    Addiction

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    40/118

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    41/118

    Addiction is Similar to Other Chronic I l lnesses Because:

    It has biological and behavioral components, both of which mustbe addressed during treatment.

    Recovery from it--protracted abstinence and restoredfunctioning--is often a long-term process requiring repeatedepisodes of treatment.

    Relapses can occur during or after treatment, and signal a need

    for treatment adjustment or reinstatement.

    Participation in support programs during and followingtreatment can be helpful in sustaining long-term recovery

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    42/118

    What is recovery?

    SAMHSA , December 2011

    Recovery from Mental Disorders and

    Substance Use Disorders:

    A process of change through which

    individuals improve their health andwellness, live a self-directed life, andstrive to reach their full potential.

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    43/118

    Through the Recovery Support Strategic Initiative, SAMHSA hasdelineated four major dimensions that support a life in recovery:

    http://blog.samhsa.gov/2011/12/22/samhsa%E2%80%99s-definition-and-guiding-principles-of-recovery-%E2%80%93-answering-the-call-for-feedback/

    Health: overcoming or managing ones disease(s) as

    well as living in a physically and emotionally healthy way;Home:a stable and safe place to live;Purpose:meaningful daily activities, such as a job,

    school, volunteerism, family caretaking, or creativeendeavors, and the independence, income and resources

    to participate in society; andCommuni ty: relationships and social networks that

    provide support, friendship, love, and hope.

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    44/118

    How many people in the US are in recovery?

    Best data wehave suggest

    20 to 40 million

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    45/118

    Emerging science of recovery Why do people seek recovery?

    What are the benefits of recovery?

    What do typical addiction careers look like?

    How many people drop out before completing Tx?Why?

    Could we have done anything so they would stayand complete? If so, what?

    What is most important to support long-termrecovery?

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    46/118

    Typical addiction career

    Number of abstinent periods one month or longer followed by return to druguse (prior to current abstinence & outside of a controlled environment)

    20 & over

    10%

    Ten to 19

    17%

    Six to nine

    7%

    Four to five16%

    Three11%

    Two

    22%

    One

    17%

    50% reported 4 or more abstinent periods followed by return to active addiction

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    47/118

    Typical treatment career

    None21

    One15

    Two12

    Three-four17

    Five to nine21

    Ten +14

    Over half of outpatient clients have had

    3 or more previous episodes

    Laudet, Stanick & Sands, Eval Review, 2007

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    48/118

    National average Tx completion rate for outpatientmodalities = 36%

    Completed40

    Left beforecompletion

    60

    NYC Outpatient treatment outcome

    Laudet, Stanick, & Sands, JSAT 2009

    f

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    49/118

    Reasons for leaving treatment

    Qualitative analyses:What is the most important reason why you dropped out of the program? *

    8.5

    9.4

    12

    12

    12

    12

    18.8

    31.6%

    0 5 10 15 20 25 30 35

    Not helpful

    Finances

    Do not want help

    Family/personal issues

    Convenience (e.g.,

    transport)

    Using

    Tx interferes w/other

    activity (e.g., job)

    Dislike

    program/staff/clients

    * Add to > 100% because up to 2 answers were coded;

    Laudet, Stanick, & Sands, JSAT 2009, 37:182-190

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    50/118

    Minimizing attrition: What could have been d one di f ferent ly so that youwould have cont inued at tending (among yes)?

    Practicalassistance

    11 Help with otherareas of

    functioning18

    Better, morecaring staff25

    Betterindividualized

    services23

    Greater flexibilityin scheduling23

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    51/118

    Promoting abstinence alone is not enough

    0 10 20 30 40 50Complete tx

    Get life together

    Relation w.family

    Housing

    Get kids back

    Educ/Voc/Training

    Get a job

    Get/Stay clean

    Abstinence is top goal but not only

    goal!!

    Asked at outpatient admission (N=314): What are the top

    pr ior i t ies in yo ur l i fe right now?

    However Extended Abstinence

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    52/118

    HoweverExtended Abstinenceis Predictive of Sustained Recovery

    It takes a year

    of abstinence

    before less thanhalf relapse

    Dennis et al, Eval Rev, 2007

    After 5 yearsif you are sober,

    you probably will stay that way.

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    53/118

    Sources of support in long-term recovery

    7

    11

    17

    18

    43

    53

    53%

    0 10 20 30 40 50 60Clinici

    ansFrien

    dsSelf/innerstreng

    thSpo

    useRecove

    ringpee

    rsFam

    ilySpirituality

    /faith

    N = 52 CCAR Membersmedian abstinence duration = 12 years

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    54/118

    The mere action of making wellness

    a bona fide outcome will reinforce the

    fact that recovery from addiction is areality for many. By extension, this

    can give hope to the many individualsand families affected by SUDs andsupport them in their search for the

    solution that will work for them.Laudet, 2009

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    55/118

    What else is driving change? Affordable Care Act and Parity Law

    More people covered More services in primary care

    settings

    Large number of people

    with SUDs still will nothave coverage

    SAPT Block Grant

    Distribution of Substance Use Problems

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    56/118

    Severe

    Substantial

    Moderate

    Mild

    None

    Alcohol, Illicit and Non-Prescribed Drugs

    2.3 Million Specialty Treatment

    ~23 Million Addiction Dxfor comparison Diabetes~24 million

    Harmful Use Dx ~60 Million

    (SBIRTnow covered)

    (Rawson, & Freese), (McLellan)

    Little or no use

    (Preventionnow covered)

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    57/118

    Screening, Brief Intervention A single event can influence individuals

    to reduce substance use for up to a year

    May reduce mortalityrates by ~ 25%

    Significantly reducessubstance-related accidentsand hospital visits

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    58/118

    http://www.drugabuse.gov/nmassist/

    Distribution of Funding

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    59/118

    Medical

    System

    SUD

    services

    Residential

    Outpatient

    Detox

    MAT

    Block Grant

    Medicaid

    Insurance

    Self pay

    CurrentFundingSources

    Tx System

    Block Grant

    Medicaid

    Insurance

    Self pay

    HCRFundingSources

    Recovery

    Support

    Distribution of Funding

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    60/118

    HEALTH CARE REFORM

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    61/118

    ROS, HCR & Integrated CareIn March 2010, President Obama signed

    into law the Patient Protection and

    Affordable Care Act and the

    Health Care and Education

    Reconciliation Act of 2010-from SAMHSA website

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    62/118

    Overarching goals of health reform

    Make health care more

    1) accessible

    2) affordable

    3) efficient, and

    4) effective

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    63/118

    Key strategies in 4 major areas: Coverage expansion

    Cant deny people for pre-existing conditions, or charge higher premiums basedon health status, caps on coverage, dropping people when they get sick, expands

    Medicaid eligibility, requires coverage beg. 2014

    Insurance reform Wellstone/Domenici Parity Act removes limits on coverage that do not apply to

    other physical ailments , states will have Insurance Exchanges that includesubsidized plans, basic required benefits, including MH/SUD services at parity

    Delivery system redesign (integration, chronicillness management, health homes),and

    Payment reform

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    64/118

    Prevention will be huge Including within chronic disease initiatives

    Co-payments removed from screening for

    depression, substance misuse,smoking cessation

    Prevention & Public HealthFund will support EBPs for

    programs that foster health,e.g. smoking cessation andcombating obesity.

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    65/118

    Numbers 32 million more Americans expected to be

    insured by 2014

    Of these, 20-30% will have MH and/or SUDs

    Increased screening will raise demand forbrief and specialty MH/SUD treatment

    Those with the most serious MH/SUDs aretwice as likely to be unemployed andtherefore still uninsured

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    66/118

    Anticipated need for BH workforce

    HCR has broad

    implications for the

    behavioral healthworkforce, not just in

    terms of capacity, but

    related to need for

    training and education

    to fulfill shifting or

    new roles

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    67/118

    Impact of ACA on BH WorkersCoverage Expansion

    More peoplegain health carecoverage withparity

    20-30%will haveMH/SUD

    Morescreening

    willidentifyeven morepeople

    We willneed anexpanded

    AND moreefficientworkforce

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    68/118

    Impact of ACA on BH WorkersWorkforce Development

    In order to improve patient satisfaction and healthoutcomes, Title V of the legislation includes

    scholarship and loan programs For work in underserved areas, schools For skills development in EBPs, cultural

    competence, C&A services

    DOL defines SUD as a distressed

    profession, i.e. lacking sufficientworkforce to meet public need Plan to recruit &train 60,000 new counselors over next

    decade (depending on funding)

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    69/118

    Impact of ACA on BH WorkersBilling, Block Grants

    We dont know more than we know

    about a lot of how things will play outMcLellan

    Level and use of block grantfunding will be impacted by whois/isnt covered and gaps that

    remain as more people gain coverage

    Organizations not proficient in billing mayneed to learn about billing models for HCR

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    70/118

    Impact of ACA on BH WorkersService Integration

    Behavioral Health and Primary Care

    By some estimates willreduce overall health carecosts by30% = $700 billion/year

    While improvingquality of care

    This report is available online athttp://www.nachc.com/research-data.cfm.

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    71/118

    Federal, state, local partners ACA is federal law, however states will

    decide much about how it is enacted

    Health exchanges, coverage for SUDs,billable services (licensed?, certified?, peers?)

    All health care is local Community partnerships, what linkages make

    sense, PC sites using SBI, who provides MAT,organizations involved in developing ROSmay be ahead of the curve

    THOUGHTS

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    72/118

    The work of HCR is just beginning; we will

    learn as we go The future of the behavioral healthworkforce, including SUD services can bedecided in large part by how well preparedwe are

    Our profession has a track record ofevolving to meet the demand for services

    THOUGHTS

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    73/118

    Partnering FQHCsFederally Qualified Health Centers are

    safety net providers for underserved populations

    141 in WV, 132 in VA (from HRSA Data Warehouse) With Medicaid expansion & funding for new

    sites, target is to double patients served to 40million by 2015

    Likely sites to be Health Homes If youve seen one FQHC, youve seen one great variability among areas, pop. Served, etc.

    http://findahealthcenter.hrsa.gov/

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    74/118

    A few of the Health Centers in West Virginia

    Pineville Childrens Center

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    75/118

    Growth of new types of services

    focused on recovery

    And recovery-or iented serv ices In formed by sc ience

    Recovery management - key

    Cultural change Advocacy

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    76/118

    Recovery Model Acute Care Model

    White (2008) Recovery Management &

    Recovery-Oriented Systems of Care: Scientif ic

    Rational & Promis ing Practices

    Substance Abusing Patient

    Non-Substance Abusing Patient

    Treatment

    Therapies,

    Meds,

    JCAHO,

    CARF, EBPs,

    etc.

    Adapted from presentation by Tom McLellan, Ph.D.

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    77/118

    Shifting to a recovery-focused model means

    ...shifting theemphasis of

    treatment from briefbiopsychosocialstabilization to one

    of sustainedrecoverymanagement

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    78/118

    Recovery Management includes pre-recovery support services to enhance

    recovery readiness,

    in-treatment recoverysupport services toenhance the strengthand stability of recovery

    initiation, and post-treatment recovery support services to

    enhance the durability and quality of recoverymaintenance.

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    79/118

    RM also includes Emphasis on resilience and recovery

    processes (asopposed to pathologyand disease processes),

    Recognition ofmultiple long-termpathways and styles of recovery,

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    80/118

    Examples of pathways to recovery

    Mutual support groupsAA, NA, Al-Anon, SOS, etc.

    Professional treatment

    inpatient, outpatient, etc.

    Recovery Community OrganizationsSAARA of Virginia

    Faith-based support services

    Celebrate Recovery, etc.

    Medication-assisted recoverymethadone, buprenorphine, etc.

    Justice system programs

    drug courts, TCs, etc.

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    81/118

    Recovery capital; problem severity, treatment failures and otherreframes

    Recovery capital (RC) isthe breadth and depth of internal andexternal resources that can be drawnupon to initiate and sustain recoveryfrom severe alcohol and other drugproblems White & Cloud, 2008

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    82/118

    Types of recovery capital Personal RC - can be

    Physical, e.g. health, financial assets,

    insurance, safe housing, etc., or

    Human, e.g. values, knowledge,educational/vocational skills, credentials,

    problem-solving skills, self-esteem,hopefulness, sense of purpose,interpersonal skills

    White & Cloud, 2008

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    83/118

    Types of recovery capital

    Family and social RC - intimaterelationships, family and kinship relationships(defined here non-traditionally, i.e., family of choice), and socialrelationships that are supportive of recovery efforts.Family/social recovery capital is indicated by willingness ofpartners and family members to participate in treatment, thepresence of others in recovery within the family and social

    network, access to sober outlets for sobriety-basedfellowship/leisure, and relational connections to conventionalinstitutions (school, workplace, church, and other communityorganizations).

    White & Cloud, 2008

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    84/118

    Types of recovery capital

    Community RC - encompassescommunity attitudes/policies/resources related to addiction and

    recovery that promote the resolution of alcohol and other drugproblems. Community recovery capital includes:

    active efforts to reduce addiction/recovery-related stigma,

    visible and diverse local recovery role models,

    a full continuum of addiction treatment/recovery resources,

    recovery mutual aid resources that are accessible and diverse, local recovery community support institutions (recovery centers,

    recovery homes, etc. and

    sources of sustained recovery support and early re-intervention

    White & Cloud, 2008

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    85/118

    Early scientific findings Recovery capitalboth its quantity and quality

    plays a major role in determining the success or

    failure of natural and assisted recovery (e.g.,recovery from AOD problems without or withparticipation in professional treatment or a recoverymutual aid society)

    Increases in recovery capital can spark turningpoints that end addiction careers, and triggerrecovery initiation

    White & Cloud, 2008

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    86/118

    Early scientific findings

    Such turning points often result after several yearsand multiple episodes of professional treatments

    Recovery capital is not equally distributedacross individuals and social groups. Members ofhistorically disempowered groups often seekrecovery from addiction lacking assets that aretaken for granted by those seeking recovery from aposition of privilege White & Cloud, 2008

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    87/118

    Early scientific findings

    Most clients with severely depleted

    family and community recovery capital gain littlefrom individually-focused addiction treatment thatfails to mobilize family and community resources

    Long-term recovery outcomes for those with the

    most severe AOD problems may have more to dowith family and community recovery capital than aparticular treatment protocol

    White & Cloud, 2008

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    88/118

    The concept of recovery capital

    reflects a shift in focus from the

    pathology of addiction to a focus onthe internal and external assetsrequired to initiate and sustain long-term recovery from alcohol and other

    drug problems.

    White & Cloud, 2008

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    89/118

    Federal Initiatives to support ROSAddiction Technology Transfer Center (ATTC) Network

    SAMHSA/CSAT funds a network of 14 regional

    ATTCs, which provide training and technicalassistance to states. The ATTC network publishesguides, toolkits and monographs supportingtreatment and recovery systems and services.These include numerous publications on recovery-specific topics. Each of the ATTCs has establisheda ROSC implementation support team to assiststates in implementing ROSC.

    http://www.attcnetwork.org/index.asphttp://www.attcnetwork.org/index.asphttp://www.attcnetwork.org/index.asphttp://www.attcnetwork.org/index.asp
  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    90/118

    Federal Initiatives to support ROSAccess to Recovery (ATR)

    (ATR)is a Substance Abuse and Mental Health

    Services Administration (SAMHSA) programwhich awards competitive grants to states andtribes to implement voucher systems forpurchasing substance use disorder treatmentand recovery support services. ATR providesstates and tribes with an excellent mechanismfor developing systems and services that moreeffectively support long-term recovery.

    http://www.atr.samhsa.gov/http://www.nattc.org/learn/topics/rosc/rss.asphttp://www.nattc.org/learn/topics/rosc/rss.asphttp://www.atr.samhsa.gov/
  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    91/118

    Federal Initiatives to support ROS Recovery Community Services Program (RCSP)

    The Recovery Community Services Program is a SAMHSA grant programwhich funds organizations to provide peer-to-peer recovery support services

    for people in or seeking recovery from alcohol and drug problems. Initiatedin 1998, RCSP has seeded the development of numerous recoverycommunity organizations.

    Targeted Capacity Expansion-Local Recovery-Oriented

    Systems of Care (TCE-ROSC)

    SAMHSAs Targeted Capacity of Expansion (TCE) Local Recovery-Oriented Systems of Care (TCE-Local ROSC) grants assist in thedevelopment of Recovery-oriented Systems of Care (ROSC) at alocal level.

    BRSS TACS Bringing Recovery Supports to Scale - current

    http://www.samhsa.gov/grants/2011/ti_11_004.aspxhttp://www.samhsa.gov/grants/2010/TI-10-007.aspxhttp://www.samhsa.gov/grants/2010/TI-10-007.aspxhttp://www.samhsa.gov/grants/2010/TI-10-007.aspxhttp://www.samhsa.gov/grants/2010/TI-10-007.aspxhttp://www.samhsa.gov/grants/2011/ti_11_004.aspx
  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    92/118

    Federal Initiatives to support ROS Partners for Recovery (PFR)

    Partners for Recoveryis a SAMHSAinitiative that supports the developmentof recovery-oriented policy, systems andservices. It engages diversestakeholders including Federal agencies,states, tribes, local governments,professional/ trade associations, faith-

    based groups, health care professionals,nurses, social workers, and recoverysupport services providers to accomplishthis.

    http://www.pfr.samhsa.gov/http://www.pfr.samhsa.gov/
  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    93/118

    ROS Implementation challenges Need for more sciencewe still know comparatively

    little from the standpoint of science about the prevalence, pathways,and styles of long-term recovery

    Integration of professionally directedservices and peer-based recovery supportwho best to provide, where are the boundaries andethical guidelines

    Service capacitieshow ought resources to bereallocated and how does this affect service capacity

    White, Kurtz, Sanders, 2006

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    94/118

    ROS Implementation challenges

    Historical and conceptual momentumwe are steeped in the acute care model, # days or sessions,continuing care almost non-existent

    Reimbursement and regulationsallbased on the acute model

    High staff turnoverin theworkforce precludes continuity of contact

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    95/118

    Recovery Community Organizations have grown andpaved a way forward one example:

    Founded 1997

    RCSP and state grants, consistentlyincreased grant funding, regular

    state funding Huge face on recovery

    Huge advocacy presence

    Multiple Recovery CommunityCenter sites

    Recovery housing network

    Recovery Coach training program

    Product development

    National leader for partnering withstate systemshttp://www.ccar.us/default.htm

    http://www.ccar.us/default.htmhttp://www.ccar.us/default.htm
  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    96/118

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    97/118

    Virginias Statewide RCO

    Substance Abuse and Addiction Recovery Alliancehttp://www.saara.org/

    SAARA of Virginia is a grassroots recovery community organization. All friends ofrecovery are invited and welcome to join. Our members include individuals inrecovery from alcohol and other drug addiction, their families, friends, anddedicated community supporters. Across the Commonwealth of Virginia, weare seventeen affiliates strong and growing. SAARA promotes social,

    educational, legal, research and health care resources and services thatsupport accessible, effective and accountable addiction prevention,intervention, treatment and Recovery. We envision the day when the stigma ofaddiction will be eradicated, and all who seek recovery will find it. Recoveryhappens! Please take a look around our website and let us know if you haveany comments or questions.

    http://www.saara.org/http://www.saara.org/
  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    98/118

    RCOs can foster ROS in systems By providing service coordination and

    modeling person-centered, strengths-

    based services

    By putting a face onrecovery

    By supporting multiplepathways to recovery

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    99/118

    RCOs can foster ROS in systems

    By providing recovery coaching and

    assertive linkages to communities ofrecovery

    By supporting recovery

    housing

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    100/118

    RCOs can foster ROS in systems By encouraging hope & optimism about

    recovery through peers

    By addressing stigma

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    101/118

    RCOs can foster ROS in systems By focusing on and modeling

    strategies for engagement andmotivational enhancement

    This

    This

    NOT

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    102/118

    ROS Outcomes: System Numbers Philadelphia

    36% in crisis utilization after 1 year

    50% cost of inpatient psychiatric services Connecticut

    46% in number of people served statewide

    62% in use of acute care

    40% in outpatient care

    25% in annual cost per client

    Outcomes: Individuals Seeking RecoverySAARA Center for Recovery in Virginia

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    103/118

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    104/118

    Recovery Oriented Services

    Have a growing evidence base for theireffectiveness

    Fit perfectly into the prioritiesfor HCR

    Include lower-cost

    interventionsfor disease/recoverymanagement

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    105/118

    Addiction is visible everywhere in thisculture, but the transformative power of

    recovery is hidden behind closed doors. Itis time we all became recovery carriers. Itis time we helped our community, ournation, and our world recover Recovery

    is contagious. Get close to it. Stay closeto it. Catch it. Keep catching it. Pass iton. (White, 2010)

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    106/118

    Where shall we go, what shall we do, and how canyou help? Implications for clinical practice

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    107/118

    Stigma

    New definitions ofaddiction, recoverybased on science

    Chronic vs. acute illness modelnew

    services, peer providers DSM-5

    Other?

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    108/118

    A study of stigmatized attitudes towards people with mentalhealth problems among health professionals.

    In J Psychiatr Ment Health Nurs. 2009 Apr;16(3):279-84.

    Summary: 108 health professionals from acute and

    mental health settings completed questionnaires.Participants had highly stigmatized attitudestowards patients with active substance usedisorders. Attitudes were less stigmatized to people

    with SUDs who wererecovering/in remission.

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    109/118

    The effectiveness of interventions for reducing stigma relatedto substance use disorders: a systematic review.

    Addiction. 2012 January; 107(1): 3950.

    Summary: Effective strategies foraddressing social stigma include

    communicating positive stories ofpeople with substance use disorders.For changing stigma at a structurallevel, contact-based training andeducation programs targeting

    medical students, clinical and otherprofessionals (e.g. police) areeffective.

    Hello, my nameis Tara and I am

    in long-termrecovery which

    means

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    110/118

    Implications of the above for clinical practice

    Stigma of addictions

    What is our responsibility for our own andothers professional attitudes?

    What is our responsibility for communityeducation to fight stigma?

    What, if any, is the responsibility ofrecovering professionals/others toadvocate?

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    111/118

    Do you think our services system as it exists today reflectsthe new, more broad definition of recovery? How/How not?

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    112/118

    The future of addiction treatment hinges on our ability toconnect treatment with recovery!

    The emerging science of recovery supports

    extending the acute care model to a model of

    recovery-oriented services that supportssustained recovery management

    Several states, communities and treatment

    organizations have begun to

    transform their systems Models for recovery management

    are already working

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    113/118

    Implications for clinical practice What do clinicians need to know about

    recovery management/chronic care?

    Do clinicians have a role in systemschange toward recovery-orientedservices and systems?

    Other?

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    114/118

    DSM-5, etc. implications for clinical practice

    What is clinicians responsibility re: the

    new DSM? Offering feedback?

    How can clinicians prepare for greaterintegration of behavioral health andprimary care?

    What other implications can you thinkof from our discussion today?

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    115/118

    New environments, new challenges, new options

  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    116/118

    http://www.williamwhitepapers.com/books_monographs/
  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    117/118

    http://www.williamwhitepapers.com/

    http://www.williamwhitepapers.com/books_monographs/http://www.williamwhitepapers.com/books_monographs/
  • 8/14/2019 DSM V C 1 - Overview of Substance Use Disorders - Kanehl.pdf

    118/118